Paul Sax
banner
paulsaxmd.bsky.social
Paul Sax
@paulsaxmd.bsky.social
Harvard/Brigham Infectious Diseases doctor, writer, educator. Editor of Clinical Infectious Diseases. Prefer baseball to football, pizza to sushi, dogs to cats, Beatles to Stones. https://blogs.jwatch.org/hiv-id-observations/
Thank you!
November 9, 2025 at 9:13 PM
Thanks, Isaac!
October 28, 2025 at 1:22 PM
Thanks, Paul! It will still mostly be ID-themed, but with less esoterica for a broader audience. And longer, more personal. At least that's how I'm planning it right now.
October 25, 2025 at 8:08 PM
Here's the personal note ... 😢 open.substack.com/pub/paulsaxm...
Louie's Last Day
Remembering Louie, and the gifts dogs give us.
open.substack.com
October 17, 2025 at 3:34 PM
Do you think clofazimine works? I can't think of a single clinical trial where a clofazimine vs a non-clofazimine arm showed that the clofazimine arm did better.

Yes, we use it -- but it sure would be nice to see some robust evidence that it's worth it.
October 7, 2025 at 9:23 PM
Very well put! So sad.

(Your dog and Louie could be related ...)
September 26, 2025 at 8:33 PM
Thanks, Ilan. It's not good news from the work-up, as suspected. He probably has only a few days or weeks left.

(That's a really cute photo of Ricotta!)
September 26, 2025 at 8:32 PM
Personally haven't used interferon for HCV in over a decade -- not since the great rush of HCV antivirals from 2013-16. Even when battling for insurance coverage, we knew that eventually we could treat people without this incredibly toxic (and not very effective) drug.
September 24, 2025 at 12:03 PM
Hooray! Working on this one clinician at a time ... next up, "DAAs" for HCV!

C'mon, when was the last time someone used a something other than a "directly acting" antiviral for HCV?
September 23, 2025 at 9:22 PM